Pharmaceutical IP and competition law in France: overview | Practical Law

Pharmaceutical IP and competition law in France: overview | Practical Law

A Q&A guide to pharmaceutical IP and competition law in France.

Pharmaceutical IP and competition law in France: overview

Practical Law Country Q&A 4-615-9355 (Approx. 17 pages)

Pharmaceutical IP and competition law in France: overview

by Marie Fillon, Mélanie Thill-Tayara and Marion Provost, Dechert LLP
Law stated as at 01 May 2018France
A Q&A guide to pharmaceutical IP and competition law in France.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in France: overview.
To compare answers across multiple jurisdictions, visit the Pharmaceutical IP and competition law Country Q&A tool.
The Q&A is part of the global guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.